Syndax Pharma

Forecast & Rating12 analysts currently cover Syndax Pharma, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $37.91, about 91.1% upside from the current price of $19.84. Price targets range from $26.00 to $57.00 — a wide spread, showing clear disagreement over just how much Syndax Pharma can rise. Historically, about 10.1% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Syndax Pharma closely still see room for the stock to rise. Data as of Aug 18, 2026; for reference only and not investment advice.